Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 10 2020 - 5:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of December 2020
Commission File Number: 001-39545
Orphazyme A/S
(Translation of registrants name into English)
Ole Maaløes Vej 3, DK-2200
Copenhagen N
Denmark
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form
20-F ☐ Form 40-F
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Orphazyme A/S
|
|
|
|
Date: December 10, 2020
|
|
By:
|
|
/s/ Georges Gemayel
|
|
|
|
|
Name
|
|
Georges Gemayel
|
|
|
|
|
Title:
|
|
Chairman of the Board
|
Orphazyme A S (CE) (USOTC:OZYMF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Orphazyme A S (CE) (USOTC:OZYMF)
Historical Stock Chart
From Jul 2023 to Jul 2024